As of January 22, 2025, Verrica Pharmaceuticals (VRCA) has a market cap of $64.872 million USD. According to our data, Verrica Pharmaceuticals is ranked No.8002 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $64.87 M |
2.33%
|
Dec 31, 2024 | $63.40 M |
-90.44%
|
Dec 29, 2023 | $0.66 B |
166.18%
|
Dec 30, 2022 | $0.25 B |
-69.98%
|
Dec 31, 2021 | $0.83 B |
-20.42%
|
Dec 31, 2020 | $1.04 B |
-27.56%
|
Dec 31, 2019 | $1.44 B |
94.97%
|
Dec 31, 2018 | $0.74 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Aclaris Therapeutics
ACRS
|
$0.28 B |
-0.000 M
|
USA
|
Journey Medical
DERM
|
$76.87 M |
22.080 M
|
USA
|
Biofrontera
BFRI
|
$7.90 M |
0.000 M
|
USA
|
Sol-Gel Technologies
SLGL
|
$25.04 M |
0.000 M
|
Israel
|
Arcutis Biotherapeutics
ARQT
|
$1.60 B |
0.000 M
|
USA
|
Intra-Cellular Therapies
ITCI
|
$13.51 B |
-0.000 M
|
USA
|
Revance Therapeutics
RVNC
|
$0.38 B |
0.000 M
|
USA
|
Evolus
EOLS
|
$0.89 B |
-0.000 M
|
USA
|
Krystal Biotech
KRYS
|
$4.41 B |
-0.000 M
|
USA
|
Cutera
CUTR
|
$9.43 M |
0.000 M
|
USA
|
Market Cap | = | VRCA Stock Price | * | VRCA Shares Outstanding |
= | $0.72 | * | 90.56 M | |
= | $64.87 M |